日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

A Prospective, Phase 1 Trial of Nivolumab, Ipilimumab, and Radiotherapy in Patients with Advanced Melanoma

一项前瞻性 I 期试验,研究纳武利尤单抗、伊匹木单抗和放射疗法治疗晚期黑色素瘤患者的疗效

Postow, Michael A; Knox, Susan J; Goldman, Debra A; Elhanati, Yuval; Mavinkurve, Vikram; Wong, Phillip; Halpenny, Darragh; Reddy, Sunil K; Vado, Kenya; McCabe, Danielle; Ramirez, Kristen Aufiero; Macri, Mary; Schwarzenberger, Paul; Ricciardi, Toni; Ryan, Aileen; Venhaus, Ralph; Momtaz, Parisa; Shoushtari, Alexander N; Callahan, Margaret K; Chapman, Paul B; Wolchok, Jedd D; Subrahmanyam, Priyanka B; Maecker, Holden T; Panageas, Katherine S; Barker, Christopher A

Rare naturally occurring immune responses to three epitopes from the widely expressed tumour antigens hTERT and CYP1B1 in multiple myeloma patients

多发性骨髓瘤患者对广泛表达的肿瘤抗原 hTERT 和 CYP1B1 的三个表位的罕见自然发生免疫反应

B Maecker, M S von Bergwelt-Baildon, K S Anderson, R H Vonderheide, K C Anderson, L M Nadler, J L Schultze